Kiwi grown products in Germany
Rua Bioscience is very pleased to announce the expansion of its medicinal cannabis product portfolio in the German market, with the launch of two new Rua-branded products cultivated entirely in New Zealand and developed from proprietary, New Zealand-sourced genetics. This marks a significant milestone in the execution of Rua’s strategy to expand into high-value international markets and to build a sustainable global portfolio.
With the addition of these two new products, Rua now has four products in Germany, the world’s largest regulated medicinal cannabis market. Demand in Germany is accelerating rapidly, with record growth in product imports in recent months. According to the latest official data from Germany’s Federal Institute for Drugs and Medical Devices (BfArM), medicinal cannabis imports reached close to 45,000kg in the recent Mar-Jun quarter of 2025, up 375% year-on-year. Premium, differentiated products, such as Rua’s are in particularly strong demand, and the expanded portfolio firmly positions Rua as a competitive supplier in this fast-growing market.
The new products are being launched in collaboration with Nimbus Health, a subsidiary of Dr. Reddy’s Laboratories and a longstanding commercial partner of Rua. Nimbus continues to deliver strong operational performance providing regulatory expertise, established market relationships, and efficient distribution to prescribing physicians and pharmacies across Germany.
With additional product launches already in development for the German market, Rua is on track to significantly grow its international sales over the next 12 months.
I te rangi nei i whakapaohotia e Rua Bioscience i te whakawhanuitanga o ana hua Rautini i te makete o Tiamana, e rua nga hua i raro o te ingoa o Rua i tipu katoatia ki Aotearoa, i tipu mai i nga ira i hua mai i Aotearoa. He kakenga whakahirahira tenei e hangai ana ki te rautaki o te kamupene kia whakawhanui ake nga hua ki nga makete nui o te ao.
Ma te tapiritanga o enei hua e rua, e wha nga hua o Rua i roto i te makete o Tiamana inaianei, te makete nui rawa atu mo te Rautini i te ao. He hiahia nui ki Tiamana mo enei hua, a kei te tipu hoki taua hiahia. E ai ki nga tataunga mo nga rongoa me nga taonga rongoa ki Tiamana (BfArM), e 45,000kg te Rautini i to mai ki ta ratou whenua mai i whenua ke i te hauwha o te Maehe ki te Hune 2025, i piki ake aua nama i te 12,000kg i taua hauwha o te tau 2024. Ko nga hua tiketike penei i o Rua nga hua e hiahiatia ana, a ma tenei whakawhanuitanga ka kitea ko Rua tetahi o nga toa o tenei makete e tere tipu ana.
Kua rewa enei hua i te taha o Nimbus Health, he apititanga o Dr Reddy’s Laboratories, a, he hoa kaipakihi o Rua. He pakari a Nimbus i ona whakahaere, he pukenga whai ture, kua tau te tu ki nga makete, a, he kaha hoki ta ratou ara hokohoko, ara tuku rongoa ki nga whakaranu ki Tiamana hoki.
Kei te hanga tonu a Rua i etahi hua hou hei tapiri ano ki te makete o Tiamana, a, he hangai te titiro o Rua ki nga hua nui ki nga makete o te ao hei te tau e heke mai nei.
If you want to understand more about international medicinal cannabis markets, go to our Global Cannabis Markets page in the Investor section for some background information.
Nga mihi nui whanau